Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
| Issued: 22 March 2006 at 11:00 |
Ref: MDA/2006/022
|
|
|
Immediate action |
|
Action |
|
|
Update |
|
|
Information request |
| Device: Baxter MiniCap peritoneal dialysis disconnect cap with povidone-iodine. |
|||||||
| Problem: The povidone-iodine contained in the disconnect caps of these peritoneal dialysis sets has the potential to be a contributing factor to thyroid changes such as hypothyroidism. Patients more likely to be affected are infants and children with smaller peritoneal fill volumes, where higher dialysate concentrations of iodine can result. |
|||||||
| Action by: All nursing, medical and technical staff using these devices. |
|||||||
|
Action: |
|||||||
|
Distributed to:
* via CE Bulletin |
>Page 2 |
||||||
| Contacts: Details of manufacturer contacts and MHRA contacts for technical and clinical aspects. Change of address or removal from address list for Healthcare Commission. |
>Page 2 |
||||||
| Appendix: Baxter Safety Alert. |
>Pages 4-6 |
|
Action deadlines for the Safety Alert Broadcast System (SABS)
|
|
|
Deadline (action underway): 29 March 2006
|
Deadline (action complete): 03 May 2006
|

